• Explore /
  • Poster
  • / Exploratory phase I study of HF1K16 for the treatment of patients with refractory/recurrent advanced glioma.

Exploratory phase I study of HF1K16 for the treatment of patients with refractory/recurrent advanced glioma.

Abstract Poster

Authors

null

Ruofan Huang

Huashan Hospital, Fudan University, Shanghai, China

Ruofan Huang , Anjie Zheng , Yuhong Xu , XIAOCHEN ZHANG , Jinsong Wu

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Breakthrough

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session A

Track

Gastrointestinal Cancer,Central Nervous System Tumors,Developmental Therapeutics,Genitourinary Cancer,Quality of Care,Healthcare Equity and Access to Care,Population Health,Viral-Mediated Malignancies

Sub Track

Immuno-therapies

Clinical Trial Registration Number

NCT05388487

Citation

J Clin Oncol 42, 2024 (suppl 23; abstr TPS32)

DOI

10.1200/JCO.2024.42.23_suppl.TPS32

Abstract #

TPS32

Poster Bd #

L4

Abstract Disclosures

Similar Posters

First Author: Eileen M. O'Reilly

First Author: Xiangrui Meng

First Author: Shubham Pant

First Author: Yu Yao